MELK and nonpapillary renal cell carcinoma: CCK-8 assays, colony formation assays, and subcutaneous tumor formation experiments demonstrated that Melk knockdown markedly increased sensitivity to sunitinib in ccRCC cells both in vitro and in vivo (Fig. 8H-I and S8B-C).